Latest Period
Q2 2026
Security Snapshot
Clearmind Medicine Inc. - Common Stock, no par value (CMND) Institutional Ownership
CUSIP: 185053501
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, no par value
- Symbol
- CMND on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 0
- Total 13F value
- $0
- Share change
- -44,962
- Value change
- -$46,214
- Number of holders
- 0
- Shares outstanding
- 1,666,306
- SEC-reported price per share
- $0.24
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CMND - Clearmind Medicine Inc. - Common Stock, no par value is tracked under CUSIP 185053501.
- 0 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 4 to 0 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $46,214 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 0 institutions filings for Q2 2026.
Security key
185053501
Latest holder period
Q2 2026
13F holders
0
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
CMND full holder history
Clearmind Medicine Inc. SEC filings
Clearmind Medicine Inc. company facts
Clearmind Medicine Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 185053501:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
CMND
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 10% | $391,190 | 166,464 | Richard Abbe | 31 Dec 2025 |
As of 30 Jun 2026, 0 institutional investors reported holding 0 shares of Clearmind Medicine Inc. - Common Stock, no par value (CMND). This represents 0% of the company’s total 1,666,306 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3